메뉴 건너뛰기




Volumn 19, Issue 56, 2000, Pages 6594-6599

Development of anticancer drugs targeting the MAP kinase pathway

Author keywords

Extracellular signal regulated kinase (ERK); MAP kinase kinase (MEK); Mitogen activated protein kinase (MAPK); Raf

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; N [5 (3 DIMETHYLAMINOBENZAMIDO) 2 METHYLPHENYL] 4 HYDROXYBENZAMIDE; UNCLASSIFIED DRUG;

EID: 0034722894     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1204083     Document Type: Review
Times cited : (306)

References (75)
  • 4
    • 0005759483 scopus 로고    scopus 로고
    • WO9932106
    • (1999)
  • 5
    • 0005719737 scopus 로고    scopus 로고
    • WO9932436
    • (1999)
  • 6
    • 0005737794 scopus 로고    scopus 로고
    • WO9932455
    • (1999)
  • 7
    • 0005756406 scopus 로고    scopus 로고
    • WO200042012
    • (2000)
  • 74
    • 0005689967 scopus 로고    scopus 로고
    • WO9822103
    • (1998)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.